The first functional role for ARL16 was established as a GTP-dependent negative regulator of innate immunity, resolving how a small GTPase could directly modulate RIG-I signaling by competing with RNA binding at RIG-I's C-terminal domain.
Evidence Co-immunoprecipitation with domain-mapping and GTP-binding mutants, RNAi knockdown with IFN-β reporter assays in cultured cells
- Endogenous stoichiometry and physiological conditions under which ARL16 inhibits RIG-I are not defined
- No GAP or GEF identified for ARL16 in the RIG-I context
- Whether ARL16's immune and ciliary functions are coordinated or independent is unknown